Skip to main content
    S

    Senti Biosciences Inc (SNTI)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.10
    -0.04 (-28.68%)

    Market Cap: $5.38M

    Last updated: Nov 17, 2026 at 4:44 PM ET

    Senti Biosciences Inc (SNTI) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Senti Biosciences (SNTI) has a latest price of $0.10 on Nov 17, 2026. Its price fell 94.0% over the past 12 months. The month-end price fell 99.8% over the 5 years through Oct 2026, a compound annual decline of 72.3%.

    Price Chart

    From May 2021 to Oct 2026, its highest month-end close was $100.90 in Oct 2021 and its lowest $0.17 in Oct 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart SNTI with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for SNTI.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 79.0%, and over 6 months it fell 89.0%. The month-end price fell 94.1% over the 3 years through Oct 2026, a compound annual decline of 61.1%.

    PeriodChange
    1 month-57.2%
    3 months-79.0%
    6 months-89.0%
    12 months-94.0%
    12 months, with dividends-94.0%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-94.1%-61.1%
    5 years-99.8%-72.3%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2024, when the price fell 46.8%, and its weakest was 2022, when it fell 85.7%.

    YearCloseChange
    2026 through Oct 2026$0.17-84.1%
    2025$1.04-70.4%
    2024$3.51-46.8%
    2023$6.60-53.2%
    2022$14.10-85.7%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 61.0% below its 50-day average of $0.25 and 85.5% below its 200-day average of $0.67.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$0.10
    50-day average$0.25-61.0%
    200-day average$0.67-85.5%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 99.0%.

    MeasureValue
    1-year beta2.48
    Largest fall, 1 year-95.9%
    Largest fall, 3 years-99.0%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About SNTI

    What is SNTI's 1-year price change?

    Senti Biosciences's price fell 94.0% over the past 12 months. With dividends included, the 12-month total return was -94.0%.

    What is SNTI's 5-year price change?

    Senti Biosciences's month-end price fell 99.8% over the 5 years through Oct 2026, a compound annual decline of 72.3%. These figures leave out dividends.

    What is SNTI's beta?

    Senti Biosciences's 1-year beta against the S&P 500 is 2.48, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 95.9%.

    Is the SNTI chart free?

    Yes. Advanced Charting for SNTI is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.